Publication:
STAT and SMAD signaling in cancer

Thumbnail Image
Files
STAT and SMAD signaling in cancer.pdf(542.02 KB)
Date
2002
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Iwamoto, T. ; Oshima, K. ; Senga, T. ; Feng, X. ; Oo, M.L. ; Hamaguchi, M. ; Matsuda, S.
item.page.secondaryauthor
item.page.director
Publisher
Murcia : F. Hernández
publication.page.editor
publication.page.department
DOI
item.page.type
info:eu-repo/semantics/article
Description
Abstract
STAT and SMAD often exert opposite biological effects on diverse cellular functions. Recent studies have shown that STAT can interface with SMAD at molecular level and that some novel molecules, such as SOCS (also called CIS) and APRO6 (also called TOB), modulate this signaling. A cofactor p300/CBP might act as a bridging molecule to mediate the interface. Thus, STAT and SMAD signaling pathways may crosstalk each other with interweaved regulatory mechanisms. Interestingly, the importance of all the proteins’ function has been shown by the increasing evidence of their involvement in cancer. These recent progresses have been made in attributing novel exciting functions. Accordingly, we would like to review the latest advances of those pathways on a cross-section in cancer signaling.
publication.page.subject
STAT , SMAD
Citation
URI
http://hdl.handle.net/10201/20808
item.page.embargo
Collections
Histology and histopathology Vol.17, nÂş 3 (2002)
Ir a EstadĂ­sticas